 In-vitro assessment hypersensitivity syndrome sorbinil Sorbinil hydantoin aldose reductase inhibitor promise therapy patients diabetic complications neuropathy retinopathy many patients sorbinil adverse reactions fever skin rash myalgia previous studies phenytoin susceptibility reactions inherited detoxification defect current study sorbinil intermediates cells patients history reaction appropriate in-vitro investigation susceptibility Microsome-generated metabolites sorbinil microM toxic normal peripheral blood lymphocytes dead cells mean SE Toxicity presence epoxide hydrolase inhibitor dead cells inhibitor cytochrome contrast cells healthy controls diabetics sorbinil dead cells cells patients reactions toxicity metabolites sorbinil phenytoin dead cells Cells patients reactions sensitive metabolites dead cells sorbinil toxic intermediate Certain patients risk hypersensitivity reactions Development important new drug uncommon severe reactions increased understanding steps development adverse reactions tests development safer compounds